尊龙凯时



      About Honz

      Honz Pharmaceutical Co., Ltd., is a publicly listed company centered on medicines for children. It devotes to becoming the leading brand in the children’s healthcare industry in China.

      Professional Production

      Honz Pharma has five highly automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong, and is constructing a new manufacturing base meeting the EU GMP standards in Zhongshan, Guangdong.

      Innovative Research & Development

      Honz Pharma emphasizes the R&D and innovation of products, has dedicated advanced equipment and exceptional R&D staff, and has invested hundreds of millions of RMB in this field.

      Product Center

      Honz Pharma has formed an integrated structure of products, created a successful line of children’s medicines centered on “Honz” branded products, and launched unique Honz star products such as “Ruizhiqing”, “Kangzhisong”, “Kangzhitai”,and “Jinlishuang”.

      Social Responsibility

      2011, Honz Pharma jointly founded the Honz Healthy Growth Foundation with the China Children and Teenagers Foundation, with the mission statement of taking care of the healthy growth of children.

      Contact Us

      Honz will carry on the cooperate legacy of “Sincere, Caring, Innovative”, and shoulder the responsibility of caring for and supporting children’s health and well-being.

      Your position is:Home>Innovative R&D>Scientific Research Achievements
      Scientific Research Achievements
      2017
      2016
      2015
      2014
      2013
      2012
      2011
      Apr.

      “The development and industrialization of Itraconazole dispersible tablet”awarded 2nd prize in 2016 Hainan scientific and technology achievement transformation event 

      Medication for children with hand-foot-mouth disease - suramin sodium for injection - completed clinical research and declared for clinical application

      Children’s medication - dextromethorphan hydrobromide film agent approved for clinical test

      Jan.

      Hainan key sci-tech project - The development and industrialization of Levocetirizine Hydrochloride Granules was checked and accepted 

      Sep.

      The establishment of“Hainan Engineering Technology Research Centre for Children’s Medication”was approved by Hainan Science & Technology Department

      Approved for 8 clinical tests including Ibuprofen phenylephrine Tablet,Ibuprofen Suspension Drops,Paracetamol Oral Suspension Fluid, Cefprozil for Suspension Drops, etc.

      May

      Levocetirizine Hydrochloride Granules obtained Pharmaceutical Registration Approval Document and started mass production

      Accomplish establishment of 3 technology platforms for Post Doctoral Research Institute: Membrane instant dissolving technology for oral cavity; Crystallization and granulation of supercritical fluid; Medication Powdery characterization. It has laid a solid scientific foundation for the corporate to build up an international standard children’s medication base; and also ensure Honz Pharma products’taste and other technical indicators maintain advantage in the same kind of products.

      Oct.

      Ceftazidime tazobactam sodium for injection - assessed to be National Key New Product 

      Dec.

      Ceftazidime tazobactam sodium for injection - assessed to be Hainan New Hi-tech Project

      Jan.

      “The development and industrialization of Nimesulide Granules”awarded 2nd prize in 2012 Hainan scientific and technology achievement transformation event

      Mar.

      I Grade new medication- Ceftazidime tazobactam sodium for injection - obtained Pharmaceutical Registration Approval Document and started mass production 

      Aug.

      Took the lead in the establishment of National Post Doctoral Research Institute; choosing children's medication as the main research direction

      Oct..

      Itraconazole dispersible Tablet and Nimesulide Granules are assessed to be  Hainan New Hi-tech products

      ZHIKE JUHONG Granules is assessed to be Haikou New Hi-tech Project

      Dec.

      “The development and industrialization of ZHIKE JUHONG KELI”awarded 2nd prize in 2013 Hainan scientific and technology achievement transformation event

      “The Manufacture Method of Nimesulide Sustained-release Tablets”patent won the gold medal in Haikou Patent Awards

      Dec.

      Identified as provincial-level technology corporate center by Hainan Industrial & Information Technology Department, Hainan Science & Technology Department and 4 other departments 

      Dec.

      The establishment of“Haikou Pediatric Pharmaceutical Engineering & Technology Research and Development Centre" was approved by Haikou Science & Information Technology Bureau

      Wechat Account:honzpharma

      Copyright by Honz Pharmaceutical Co.,Ltd.    All rights reserved


        XML地图